A multicenter, randomized, double-blind, placebo-controlled trial of recombinant human interleukin-10 in HIV-infected subjects

JB Angel, MA Jacobson, PR Skolnik, M Giordano… - Aids, 2000 - journals.lww.com
JB Angel, MA Jacobson, PR Skolnik, M Giordano, L Shapiro, A LeBeaut, W Greaves…
Aids, 2000•journals.lww.com
A multicenter, randomized, double-blind, placebo-controlled... : AIDS A multicenter, randomized,
double-blind, placebo-controlled trial of recombinant human interleukin-10 in HIV-infected
subjects : AIDS Log in or Register Subscribe to journalSubscribe Get new issue alertsGet alerts
Submit your manuscript Secondary Logo Journal Logo Advanced Search Toggle navigation
Subscribe Register Login Articles & Issues For Authors Journal Info Advanced Search
November 10, 2000 - Volume 14 - Issue 16 Previous Article Next Article Clinical A multicenter …
Abstract
Objective
To determine the effect of multiple subcutaneous doses of recombinant human interleukin (rhuIL)-10 on plasma HIV RNA levels and CD4 T-cell counts, and to evaluate its safety and tolerability in HIV-infected subjects.
Design
Lippincott Williams & Wilkins
Show moreShow less
Save Cite Cited by 42 Related articles All 7 versions